Pfizer’s top strategy executive is leaving (PFE:NYSE)

robot
Abstract generation in progress

Pfizer’s Chief Strategy and Innovation Officer, Andrew Baum, who was hired in 2024 to redefine the company’s strategic direction, is set to depart later this year. This news comes from a research note issued by BMO Capital Markets. Baum’s departure signifies a new change in leadership and strategic oversight for the pharmaceutical giant.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin